Faculty profile

Sharon Walmsley

ResearcherMcGill University

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a McGill University directory, so their courses and email address may be missing. Find their university profile.

Sharon Walmsley

Researcher

Health Sciences

McGill University

Montreal, Quebec, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
1 publication in the last five years, latest in 2022.
Principal investigator on 1 research grant (1 CIHR), most recently in 2024.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

160

Citations

h-index

105

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Clinical Trials Community Engaged Cure Hepatitis B And C Hiv/Aids Network Prevention Sexually Transmitted And Blood Borne Infections

Latest papers

Monkeypox Virus Infection in Humans across 16 Countries - April-June 2022.
The New England journal of medicine · 2022
Viral suppression and viral rebound among young adults living with HIV in Canada.
Medicine · 2018
Pathways From HIV-Related Stigma to Antiretroviral Therapy Measures in the HIV Care Cascade for Women Living With HIV in Canada
Journal of acquired immune deficiency syndromes (1999) · 2018

All 11 publications

Latest funding

CIHR Pan-Canadian Network for HIV/AIDS and Sexually Transmitted and Blood Borne Infections (STBBI) Clinical Trials Research (CTN)
CIHR · 2024 · Principal investigator
$25,000,000
After the Cure: Measuring the full impacts of direct acting antivirals for people living with HIV/hepatitis C virus coinfection in Canada
CIHR · 2022 · Co-investigator
$100,000
After the Cure: Measuring the full impacts of direct-acting antivirals for people living with HIV/hepatitis C virus coinfection in Canada
CIHR · 2022 · Co-investigator
$1,587,376

All 6 grants and awards

11 publications.

Monkeypox Virus Infection in Humans across 16 Countries - April-June 2022.

Thornhill JP, Barkati S, Walmsley S, Rockstroh J, Antinori A, Harrison LB, Palich R, Nori A, Reeves I, Habibi MS, Apea V, Boesecke C, Vandekerckhove L, Yakubovsky M, Sendagorta E, Blanco JL, Florence E, Moschese D, Maltez FM, Goorhuis A, Pourcher V, Migaud P, Noe S, Pintado C, Maggi F, Hansen AE, Hoffmann C, Lezama JI, Mussini C, Cattelan A, Makofane K, Tan D, Nozza S, Nemeth J, Klein MB, Orkin CM, SHARE-net Clinical Group

The New England journal of medicine2022

DOI: 10.1056/nejmoa2207323 PMID: 35866746

Viral suppression and viral rebound among young adults living with HIV in Canada.

Palmer A, Gabler K, Rachlis B, Ding E, Chia J, Bacani N, Bayoumi AM, Closson K, Klein M, Cooper C, Burchell A, Walmsley S, Kaida A, Hogg R, Canadian Observational Cohort (CANOC) Collaboration

Medicine2018

DOI: 10.1097/md.0000000000010562 PMID: 29851775

Pathways From HIV-Related Stigma to Antiretroviral Therapy Measures in the HIV Care Cascade for Women Living With HIV in Canada

Logie CH, Lacombe-Duncan A, Wang Y, Kaida A, Conway T, Webster K, de Pokomandy A, Loutfy MR, Anema A, Becker D

Journal of acquired immune deficiency syndromes (1999)201866 citations

DOI: 10.1097/qai.0000000000001589

A Multi-State Model Examining Patterns of Transitioning Among States of Engagement in Care in HIV-Positive Individuals Initiating Combination Antiretroviral Therapy.

Gillis J, Loutfy M, Bayoumi AM, Antoniou T, Burchell AN, Walmsley S, Cooper C, Klein MB, Machouf N, Montaner JS, Rourke SB, Tsoukas C, Hogg R, Raboud J, CANOC Collaboration

Journal of acquired immune deficiency syndromes (1999)2016

DOI: 10.1097/qai.0000000000001109 PMID: 27851713

Frequent injection cocaine use increases the risk of renal impairment among hepatitis C and HIV coinfected patients.

Rossi C, Cox J, Cooper C, Martel-Laferrière V, Walmsley S, Gill J, Sapir-Pichhadze R, Moodie EE, Klein MB, Canadian Co-infection Cohort Investigators

AIDS (London, England)2016

DOI: 10.1097/qad.0000000000001060 PMID: 26859371

Mortality in HIV-hepatitis C co-infected patients in Canada compared to the general Canadian population (2003-2013).

Klein MB, Rollet-Kurhajec KC, Moodie EE, Yaphe S, Tyndall M, Walmsley S, Gill J, Martel-Laferriere V, Cooper C, Canadian Co-infection Cohort Investigators

AIDS (London, England)2014

DOI: 10.1097/qad.0000000000000377 PMID: 25259703

High level antibody avidity is achieved in HIV-seropositive recipients of an inactivated split adjuvanted (AS03A) influenza vaccine.

Yam KK, Gipson E, Klein M, Walmsley S, Haase D, Halperin S, Scheifele D, Ward BJ, Cooper C

Journal of clinical immunology2014

DOI: 10.1007/s10875-014-0054-z PMID: 24824648

Marijuana smoking does not accelerate progression of liver disease in HIV-hepatitis C coinfection: a longitudinal cohort analysis.

Brunet L, Moodie EE, Rollet K, Cooper C, Walmsley S, Potter M, Klein MB, Canadian Co-infection Cohort Investigators

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America2013

DOI: 10.1093/cid/cit378 PMID: 23811492

Who needs direct-acting antivirals for HCV? Challenges faced in advancing HCV therapy for HIV-HCV-coinfected individuals.

Klein MB, Rollet KC, Hull M, Cooper C, Walmsley S, Conway B, Pick N, Canadian Co-infection Cohort Study (CTN222) Investigators

Antiviral therapy2013

DOI: 10.3851/imp2484 PMID: 23211632

Cohort Profile: The Canadian HIV–Hepatitis C Co-infection Cohort Study

Klein MB, Saeed S, Yang H, Cohen J, Conway B, Cooper C, Côté P, Cox J, Gill J, Haase D

International Journal of Epidemiology201094 citationsSenior authorOpen Access

DOI: 10.1093/ije/dyp297 PMID: W2163373419

CIHR Pan-Canadian Network for HIV/AIDS and Sexually Transmitted and Blood Borne Infections (STBBI) Clinical Trials Research (CTN)

Principal investigatorCIHR2024HIV/AIDS & STBBI Clinical Trials Research Network - Phase 1

Principal investigators: Klein, Marina B; Habanyama, Muluba; Mandarino, Enrico; Martin, Carrie; Angel, Jonathan B; Anis, Aslam H; Brophy, Jason C; Burchell, Ann N; Coffin, Carla S; Costiniuk, Cecilia T; Daley, Peter; Durand, Madeleine; Fontaine, Guillaume; Golchi, Shirin; Grennan, Jonathan (Troy); Hart, Trevor A; Hull, Mark W; Keynan, Yoav; King, Elizabeth M; Kronfli, Nadine; Law, John Lok Man; Lebouché, Bertrand; Logie, Carmen; Mbuagbaw, Lawrence C; McGuinty, Michaeline; Murray, Melanie C; Shaw, Souradet Y; Smyth, Daniel J; Spence, Cara J; Tan, Darrell H; Walmsley, Sharon L; Wong, Alexander C; Worthington, Catherine A; Zhabokritsky, Alice

Keywords: Clinical Trials; Community Engaged; Cure; Hepatitis B And C; Hiv/Aids; Network; Prevention; Sexually Transmitted And Blood Borne Infections; Syphilis; Treatment

$25,000,000

After the Cure: Measuring the full impacts of direct acting antivirals for people living with HIV/hepatitis C virus coinfection in Canada

Co-investigatorCIHR2022Project Grant

Principal investigators: Klein, Marina B

Keywords: Access To Care; Co-Infection; Cure; Direct Acting Antivirals; Fibrosis Progression; Health Outcomes; Hepatitis C Virus; Hiv; Prospective Cohort Study; Re-Infection

$100,000

After the Cure: Measuring the full impacts of direct-acting antivirals for people living with HIV/hepatitis C virus coinfection in Canada

Co-investigatorCIHR2022Project Grant

Principal investigators: Klein, Marina B

Keywords: Access To Care; Co-Infection; Cure; Direct Acting Antivirals; Fibrosis Progression; Health Outcomes; Hepatitis C Virus; Hiv; Prospective Cohort Study; Re-Infection

$1,587,376

The role of fatty liver in the epidemic of advanced chronic liver disease among people living with HIV

Co-investigatorCIHR2019Project Grant

Principal investigators: Sebastiani, Giada

Keywords: Advanced Chronic Liver Disease; Biobank; Biological Sex; Fatty Liver; Fibroscan; Healthcare Resource Utilization; Hiv; Patient Reported Outcomes; Risk Score

$685,440

The Coming Revolution in HCV Therapy: Will HIV-HCV co-infected patients really benefit?

Co-investigatorCIHR2014Operating Grant - Priority Announcement : Hepatitis C (bridge)

Principal investigators: Klein, Marina B

Keywords: Access To Treatment; Cost-Effectivness Analysis; Direct Antiviral Agents (Daas); End-Stage Liver Disease (Esld); Health Economics; Health Outcomes; Hepatitis C (Hcv); Hepatitis C Treatment; Hiv; Models Of Care

Stemming the epidemic of liver related morbidity and mortality in HIV-HCV co-infection: Is ART enough?

Co-investigatorCIHR2009Operating Grant

Principal investigators: Klein, Marina B

Keywords: Antiretroviral Therapy; Co-Infection; Hepatitis C Virus; Hiv; Immunopathogenesis; Prospective Cohort Study

$1,924,155

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Something wrong or missing on this profile? Suggest a correction

Sharon Walmsley

Research

Latest papers

Latest funding

Monkeypox Virus Infection in Humans across 16 Countries - April-June 2022.

Viral suppression and viral rebound among young adults living with HIV in Canada.

Pathways From HIV-Related Stigma to Antiretroviral Therapy Measures in the HIV Care Cascade for Women Living With HIV in Canada

A Multi-State Model Examining Patterns of Transitioning Among States of Engagement in Care in HIV-Positive Individuals Initiating Combination Antiretroviral Therapy.

Frequent injection cocaine use increases the risk of renal impairment among hepatitis C and HIV coinfected patients.

Mortality in HIV-hepatitis C co-infected patients in Canada compared to the general Canadian population (2003-2013).

High level antibody avidity is achieved in HIV-seropositive recipients of an inactivated split adjuvanted (AS03A) influenza vaccine.

Marijuana smoking does not accelerate progression of liver disease in HIV-hepatitis C coinfection: a longitudinal cohort analysis.

Who needs direct-acting antivirals for HCV? Challenges faced in advancing HCV therapy for HIV-HCV-coinfected individuals.

Cohort Profile: The Canadian HIV–Hepatitis C Co-infection Cohort Study

CIHR Pan-Canadian Network for HIV/AIDS and Sexually Transmitted and Blood Borne Infections (STBBI) Clinical Trials Research (CTN)

After the Cure: Measuring the full impacts of direct acting antivirals for people living with HIV/hepatitis C virus coinfection in Canada

After the Cure: Measuring the full impacts of direct-acting antivirals for people living with HIV/hepatitis C virus coinfection in Canada

The role of fatty liver in the epidemic of advanced chronic liver disease among people living with HIV

The Coming Revolution in HCV Therapy: Will HIV-HCV co-infected patients really benefit?

Stemming the epidemic of liver related morbidity and mortality in HIV-HCV co-infection: Is ART enough?

Frequent collaborators

Sharon Walmsley

Curtis Cooper

Curtis Cooper

Sharon Walmsley

Curtis Cooper

Marina Klein

Curtis Cooper

Curtis Cooper

Robert Hogg

John Gill

Christos Tsoukas

Angela Kaida

Ann Burchell

Marina Klein

Ann Burchell

Janet Raboud

Christos Tsoukas

Christos Tsoukas

Ann Burchell

Robert Hogg

Angela Kaida

Janet Raboud

Marina Klein

Robert Hogg

Lori Brotto

Claudette Cardinal

Greta Bauer

Renee Masching

Sharon Walmsley

Claudette Cardinal